AAPL 206.98 +2.37 (+1.16%)MSFT 124.94 +1.19 (+0.96%)FB 183.46 +1.67 (+0.92%)ZNGA 5.62 +0.1 (+1.81%)NVDA 191.36 +2.88 (+1.53%)WBA 53.72 -0.38 (-0.69%)GOOG 1266.32 +17.6 (+1.41%)PIH 5.25 -0.05 (-0.94%)
AAPL 206.98 +2.37 (+1.16%)MSFT 124.94 +1.19 (+0.96%)FB 183.46 +1.67 (+0.92%)ZNGA 5.62 +0.1 (+1.81%)NVDA 191.36 +2.88 (+1.53%)WBA 53.72 -0.38 (-0.69%)GOOG 1266.32 +17.6 (+1.41%)PIH 5.25 -0.05 (-0.94%)

Cash Flow AMPH Quote Amphastar P

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
NetIncome -3 11 5
Depreciation 13 15 15
DeferredIncomeT -8 -4 4
StockBasedCompe 13 15 17
AccountsReceiva -11 6 -8
InventoryCS 10 -10 19
AccountsPayable 0 0 0
OtherWorkingCap -3 3 -5
OtherNonCashIte 0 2 -2
NetCashProvided 11 39 39
InvestmentsInPP -14 -21 -35
AcquisitionsNet 0 -12 0
PurchasesOfInve 0 -4 -6
SalesMaturities 0 3 4
PurchasesOfInta 0 0 0
OtherInvestingA -3 -5 -4
NetCashUsedForI -17 -40 -39
DebtIssued 7 10 19
DebtRepayment -9 -15 -10
CommonStockIssu 15 21 14
CommonStockRepu -10 -10 -31
DividendPaid 0 0 0
OtherFinancingA 0 1 0
NetCashProvided 2 7 -8
NetChangeInCash -2 6 -7
CashAtBeginning 68 66 72
CashAtEndOfPeri 66 72 66
Amphastar Pharmaceuticals Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Amphastar Pharmaceuticals Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.